Literature DB >> 27528846

Pulmonary Surveillance Strategies Following Sarcoma Excision Vary Among Orthopedic Oncologists: A Survey of the Musculoskeletal Tumor Society.

Zachary Ries1, C Parker Gibbs2, Mark T Scarborough2, Benjamin J Miller1.   

Abstract

BACKGROUND: Pulmonary surveillance protocols following sarcoma excision based on clinical evidence and outcomes are limited in current literature. The purpose of this study was to determine the method, frequency, and reasoning behind pulmonary surveillance strategies in patients treated for sarcoma among members of the Musculoskeletal Tumor Society (MSTS).
METHODS: SurveyMonkey, an online survey tool, was used to create and distribute a questionnaire to 211 members of the MSTS in 2011. The 16 questions focused on current pulmonary surveillance algorithms and their reasoning.
RESULTS: Of the surveyed members of the MSTS, 65% follow high-grade sarcoma with routine chest CT scans. Most disagreement involved low-grade sarcomas, where radiographs (34%), routine CT (33%), or selective CT scans (31%) were evenly distributed. Selective CT scans in low-grade lesions were warranted with an indeterminate nodule on prior CT (81%), local recurrence (40%), or large/ deep tumor characteristics (31%). Most protocols were based on continuation of training protocols (46%), clinician's interpretation of the current literature (23%), or personal experience (14%).
CONCLUSIONS: Significant clinician variability exists in terms of pulmonary surveillance of sarcomas, most notably in low-grade lesions. The results of this study represent an area in need of further study to develop an evidence-based protocol for sarcoma pulmonary surveillance.

Entities:  

Mesh:

Year:  2016        PMID: 27528846      PMCID: PMC4910805     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  29 in total

1.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Authors:  Amy Berrington de González; Sarah Darby
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

2.  Benefit of surgical treatment of lung metastasis in soft tissue sarcoma.

Authors:  Alexander Rehders; Stefan B Hosch; Peter Scheunemann; Nikolas H Stoecklein; Wolfram T Knoefel; Matthias Peiper
Journal:  Arch Surg       Date:  2007-01

Review 3.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

4.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

Authors:  P W Pisters; D H Leung; J Woodruff; W Shi; M F Brennan
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

5.  Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

Authors:  K G Billingsley; M E Burt; E Jara; R J Ginsberg; J M Woodruff; D H Leung; M F Brennan
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

6.  Primary extremity sarcoma: what is the appropriate follow-up?

Authors:  B P Whooley; J F Gibbs; M M Mooney; B E McGrath; W G Kraybill
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

7.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

8.  Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

Authors:  M Weiss; C L Loprinzi; E T Creagan; R J Dalton; P Novotny; J R O'Fallon
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

9.  CT scans for pulmonary surveillance may be overused in lower-grade sarcoma.

Authors:  Benjamin J Miller; Emily E Carmody Soni; John D Reith; C Parker Gibbs; Mark T Scarborough
Journal:  Iowa Orthop J       Date:  2012

Review 10.  Radiation risks from exposure to chest computed tomography.

Authors:  Michael V Huppmann; William B Johnson; Marcia C Javitt
Journal:  Semin Ultrasound CT MR       Date:  2010-02       Impact factor: 1.875

View more
  5 in total

1.  Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.

Authors:  David A J Wilson; Aaron Gazendam; Julia Visgauss; David Perrin; Anthony M Griffin; Peter W Chung; Charles N Catton; David Shultz; Peter C Ferguson; Jay S Wunder
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

2.  Linear mixed-effects models for estimation of pulmonary metastasis growth rate: implications for CT surveillance in patients with sarcoma.

Authors:  Ulysses Isidro; Liam M O'Brien; Ronnie Sebro
Journal:  Br J Radiol       Date:  2020-08-26       Impact factor: 3.039

3.  Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey.

Authors:  Patricia Schneider; Victoria Giglio; Dana Ghanem; David Wilson; Robert Turcotte; Marc Isler; Sophie Mottard; Benjamin Miller; James Hayden; Yee-Cheen Doung; Kenneth Gundle; R Lor Randall; Kevin Jones; Roberto Vélez; Michelle Ghert
Journal:  BMJ Open       Date:  2021-02-26       Impact factor: 2.692

4.  The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial.

Authors: 
Journal:  BMJ Open       Date:  2019-09-18       Impact factor: 2.692

5.  The Utility of Chest Imaging for Surveillance of Atypical Lipomatous Tumors.

Authors:  Alexander L Lazarides; Harrison R Ferlauto; Zachary D C Burke; Anthony M Griffin; Bruce D Leckey; Nicholas M Bernthal; Jay S Wunder; Peter C Ferguson; Julia D Visgauss; Brian E Brigman; William C Eward
Journal:  Sarcoma       Date:  2021-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.